Advertisement
UK markets closed
  • FTSE 100

    8,139.83
    +60.97 (+0.75%)
     
  • FTSE 250

    19,824.16
    +222.18 (+1.13%)
     
  • AIM

    755.28
    +2.16 (+0.29%)
     
  • GBP/EUR

    1.1679
    +0.0022 (+0.19%)
     
  • GBP/USD

    1.2494
    -0.0017 (-0.13%)
     
  • Bitcoin GBP

    51,079.78
    -571.98 (-1.11%)
     
  • CMC Crypto 200

    1,327.94
    -68.59 (-4.91%)
     
  • S&P 500

    5,099.96
    +51.54 (+1.02%)
     
  • DOW

    38,239.66
    +153.86 (+0.40%)
     
  • CRUDE OIL

    83.66
    +0.09 (+0.11%)
     
  • GOLD FUTURES

    2,349.60
    +7.10 (+0.30%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     
  • HANG SENG

    17,651.15
    +366.61 (+2.12%)
     
  • DAX

    18,161.01
    +243.73 (+1.36%)
     
  • CAC 40

    8,088.24
    +71.59 (+0.89%)
     

Want Rising Passive Income? Consider These 2 Stocks for Your Portfolio

Want Rising Passive Income? Consider These 2 Stocks for Your Portfolio

Serving more than 100 million customers through its pharmacy benefit manager CVS Caremark and managed care company Aetna, CVS Health (NYSE: CVS) is a company critical to the healthcare sector. It's a safe bet that as long as there is still a need for prescriptions and health insurance, the company will likely do well for its shareholders. This is why analysts believe that CVS Health's non-GAAP (generally accepted accounting principles) adjusted diluted earnings per share (EPS) will compound by 5.9% annually over the next five years.